Use of N-arylheteroarylalkyl imidazol-2-one compounds for treatm

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514341, A61K 3144

Patent

active

054419700

ABSTRACT:
##STR1## A class of N-arylheteroarylalkyl imidazol-2-one compounds is described for use in treatment of circulatory disorders such as hypertension and congestive heart failure. Compounds of particular interest are angiotensin II antagonists of formula (I) wherein A is selected from (a), (b), (c), (d), (e) and (f), wherein m is one; R.sup.1 is selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, neopentyl, phenyl, methylphenyl, difluorophenyl, benzyl, phenetyl, cyclohexyl, cyclohexylmethyl, cyclohexylethyl, cyclohexanoyl, 1-oxo-2-cyclohexylethyl, benzoyl, 1-oxo-2-phenethyl, 1-oxopropyl, 1-oxobutyl, 1-oxopentyl and 2-hydroxybutyl; wherein R.sup.0 is hydrido; wherein R.sup.2 is selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, neopentyl, phenyl, benzyl, phenethyl, cyclohexyl, cyclohexylmethyl, propylthio, butylthio, and hydroxyalkyl; wherein each of R.sup.3, R.sup.4, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10 and R.sup.11 is hydrido and R.sup.5 must be seleted from COOH, SH, PO.sub.3 H.sub.2, SO.sub.3 H, CONHNH.sub.2, CONHNHSO.sub.2 CF.sub.3, OH, (g), (h) and (i) wherein each of R.sup.42 and R.sup.43 is independently selected from chloro, cyano, nitro, trifluoromethyl, methoxycarbonyl and trifluoromethylsulfonyl; or a tautomer thereof or a pharmaceutically-acceptable salt thereof.

REFERENCES:
patent: 4816463 (1989-03-01), Blankley et al.
patent: 4880804 (1989-11-01), Carini et al.
P. C. Wong et al., J. Pharmacol. Exp. ther., 247(1), 1-7 (1988).
A. T. Chiu et al, European J. Pharmacol., 157, 13-21 (1988).
A. T. Chiu et al, J. Pharmacol. Exp. Ther., 250 (3), 867-874 (1989).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of N-arylheteroarylalkyl imidazol-2-one compounds for treatm does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of N-arylheteroarylalkyl imidazol-2-one compounds for treatm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of N-arylheteroarylalkyl imidazol-2-one compounds for treatm will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2181994

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.